BCAR4, which has a crucial role in tamoxifen-resistance breast cancer, can bind to the promoter region of GLI2 and activate the GLI2 downstream genes, making the prostate cancer cells less sensitive to androgen stimulation54. This evidence concerns the gene GLI2 and breast cancer.